Jacobs Levy Equity Management, Inc Biotechnology

Jacobs Levy Equity Management, Inc

$23.9 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TNGX Tango Therapeutics, Inc.	$423M	$1.01 Million 0.0% of portfolio	737,955	Q1 2025 Added 42.62%
FHTX Foghorn Therapeutics Inc.	$197M	$882,000 0.0% of portfolio	241,816	Q1 2025 Added 8.06%
ADPT Adaptive Biotechnologies Corp	$1.48B	$869,000 0.0% of portfolio	117,069	Q1 2025 Reduced 21.99%
SGMO Sangamo Therapeutics, Inc	$72M	$856,000 0.0% of portfolio	1,297,785	Q1 2025 Added 74.79%
MGNX Macrogenics Inc	$80.5M	$844,000 0.0% of portfolio	665,351	Q1 2025 Added 17.57%
BEAM Beam Therapeutics Inc.	$1.18B	$843,000 0.0% of portfolio	43,199	Q1 2025 New
ETNB 89bio, Inc.	$469M	$718,000 0.0% of portfolio	98,848	Q1 2025 New
ETON Eton Pharmaceuticals, Inc.	$343M	$704,000 0.0% of portfolio	54,275	Q1 2025 New
OMER Omeros Corp	$198M	$702,000 0.0% of portfolio	85,514	Q1 2025 Reduced 18.2%
SEER Seer, Inc.	$118M	$614,000 0.0% of portfolio	363,355	Q1 2025 Added 124.48%
ZNTL Zentalis Pharmaceuticals, Inc.	$74.1M	$554,000 0.0% of portfolio	348,965	Q1 2025 Added 50.38%
REGN Regeneron Pharmaceuticals, Inc.	$54.6B	$473,000 0.0% of portfolio	747	Q1 2025 Reduced 11.81%
MRSN Mersana Therapeutics, Inc.	$35M	$453,000 0.0% of portfolio	1,333,124	Q1 2025 Added 19.89%
CTMX Cytom X Therapeutics, Inc.	$152M	$439,000 0.0% of portfolio	686,208	Q1 2025 Reduced 55.65%
FULC Fulcrum Therapeutics, Inc.	$354M	$425,000 0.0% of portfolio	147,654	Q1 2025 New
VIR Vir Biotechnology, Inc.	$694M	$359,000 0.0% of portfolio	55,452	Q1 2025 New
AVIR Atea Pharmaceuticals, Inc.	$271M	$353,000 0.0% of portfolio	118,167	Q1 2025 Reduced 69.77%
IKNA Ikena Oncology, Inc.	$49.3M	$314,000 0.0% of portfolio	245,485	Q1 2025 Reduced 25.02%
GOSS Gossamer Bio, Inc.	$135M	$310,000 0.0% of portfolio	282,264	Q1 2025 Reduced 81.61%
LYEL Lyell Immunopharma, Inc.	$2.15B	$301,000 0.0% of portfolio	558,979	Q1 2025 Reduced 59.65%
ARVN Arvinas, Inc.	$396M	$300,000 0.0% of portfolio	42,810	Q1 2025 New
OLMA Olema Pharmaceuticals, Inc.	$165M	$281,000 0.0% of portfolio	74,919	Q3 2024 Reduced 14.28%
AMLX Amylyx Pharmaceuticals, Inc.	$296M	$272,000 0.0% of portfolio	77,091	Q1 2025 Reduced 75.52%
MDXG Mimedx Group, Inc.	$675M	$231,000 0.0% of portfolio	30,516	Q1 2025 New
PRTA Prothena Corp Public LTD CO	$268M	$229,000 0.0% of portfolio	18,553	Q1 2025 New
ALDX Aldeyra Therapeutics, Inc.	$181M	$218,000 0.0% of portfolio	37,984	Q1 2025 New
VYGR Voyager Therapeutics, Inc.	$113M	$218,000 0.0% of portfolio	64,524	Q1 2025 New
NAUT Nautilus Biotechnology, Inc.	$91M	$193,000 0.0% of portfolio	225,098	Q1 2025 New
PMVP Pmv Pharmaceuticals, Inc.	$49.7M	$141,000 0.0% of portfolio	129,914	Q1 2025 Reduced 75.94%
STTK Shattuck Labs, Inc.	$40.3M	$81,000 0.0% of portfolio	85,638	Q1 2025 New
GBIO Generation Bio Co.	$22.4M	$72,000 0.0% of portfolio	182,005	Q1 2025 Reduced 41.58%
DSGN Design Therapeutics, Inc.	$209M	$67,000 0.0% of portfolio	17,482	Q1 2025 Reduced 4.27%
OVID Ovid Therapeutics Inc.	$21.1M	$62,000 0.0% of portfolio	200,593	Q1 2025 Reduced 31.23%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.